Author:
Kang Guson,Banerjee Dipanjan
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference21 articles.
1. McMurray JJV, Packer M, Desai AS, et al. Angiotensin–Neprilysin inhibition versus Enalapril in heart failure. N Engl J Med. 2014;371(11):140830040023009. doi: 10.1056/NEJMoa1409077 .
2. Jessup M. Neprilysin inhibition--a novel therapy for heart failure. N Engl J Med. 2014;371(11):1062–4. doi: 10.1056/NEJMe1409898 .
3. Sacks CA, Jarcho JA, Curfman GD. Paradigm shifts in heart-failure therapy--a timeline. N Engl J Med. 2014;371(11):989–91. doi: 10.1056/NEJMp1410241 .
4. Roques BP, Fournié-Zaluski MC, Soroca E, et al. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature. 1980;288(5788):286–8. http://www.ncbi.nlm.nih.gov/pubmed/7001254 . Accessed February 22, 2016.
5. Sybertz EJ, Chiu PJ, Vemulapalli S, et al. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats. J Pharmacol Exp Ther. 1989;250(2):624–31. http://www.ncbi.nlm.nih.gov/pubmed/2547941 . Accessed February 22, 2016.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献